Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: Molecular evidence for a pathology of dendritic spines

American Journal of Psychiatry

Volumn 161, Issue 10, 2004, Pages 1848-1855

  Law, Amanda J ^a   Weickert, Cynthia Shannon ^b   Hyde, Thomas M ^b   Kleinman, Joel E ^b   Harrison, Paul J ^b  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CYCLOPHILIN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN 2; NERVE PROTEIN; NEUROLEPTIC AGENT; SPINOPHILIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC SPINE; ENTORHINAL CORTEX; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR DEPRESSION; MALE; MOOD DISORDER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SUBICULUM; SYNAPSE;

EID: 2342508828     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.161.10.1848     Document Type: Article

References (64)

1. Harrison PJ: The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain 1999; 122:593-624
2. Selemon LD, Goldman-Rakic PS: The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 1999; 45:17-25
3. Honer WG, Young C, Falkai P: Synaptic pathology, in The Neuropathology of Schizophrenia: Progress and Interpretation. Edited by Harrison PJ, Roberts GW. Oxford, UK, Oxford University Press, 2000, pp 105-136
4. Feinberg I: Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1982; 17:319-334
5. Stevens JR: Abnormal reinnervation as a basis for schizophrenia: a hypothesis. Arch Gen Psychiatry 1992; 49:238-243
6. McGlashan TH, Hoffman RE: Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 2000; 57:637-648
7. Costa E, Davis J, Grayson DR, Guidotti A, Pappas GD, Pesold C: Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol Dis 2001; 8:723-742
8. Mirnics K, Middleton FA, Lewis DA, Levitt P: Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 2001; 24:479-486
9. Moises HW, Zoega T, Gottesman II: The glial growth factors deficiency and synaptic destabilisation hypothesis of schizophrenia. BMC Psychiatry 2002; 2:8
10. Frankle WG, Lerma J, Laruelle M: The synaptic hypothesis of schizophrenia. Neuron 2003; 39:205-216
11. Harrison PJ, Owen MJ: Genes for schizophrenia? recent findings and their pathophysiological implications. Lancet 2003; 361:417-419
12. Eastwood SL, Cairns NJ, Harrison PJ: Synaptophysin gene expression in schizophrenia: investigations of synaptic pathology in the cerebral cortex. Br J Psychiatry 2000; 176:236-242
13. Eastwood SL, Burnet PWJ, Harrison PJ: Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 1995; 66:309-319
14. Eastwood SL, Harrison PJ: Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 1995; 69:339-343
15. Eastwood SL, Harrison PJ: Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections. Neuroscience 1999; 93:99-106
16. Webster MJ, Weickert CS, Herman MM, Hyde TM, Kleinman JE: Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia. Schizophr Res 2001; 49:89-98
17. Harrison PJ, Eastwood SL: Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 2001; 11:508-519
18. Harrison PJ, Eastwood SL: Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 1998; 352:1669-1673
19. Harrison PJ, Law AJ, Eastwood SL: Glutamate receptors and transporters in the hippocampus in schizophrenia. Ann NY Acad Sci USA 2003; 1003:94-101
20. Sawada K, Barr AM, Takahashi S, Arima K, Falkai P, Phillips A, Honer WG: Complexins I and II in hippocampus in schizophrenia (abstract). Schizophr Res 2003; 60(suppl):74-75
21. Weinberger DR: Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 1999; 45:395-402
22. Heckers S: Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus 2001; 11:520-528
23. Rosoklija G, Toomayan G, Ellis SP, Keilp J, Mann JJ, Latov N, Hays AP, Dwork AJ: Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 2000; 57:349-356
24. Arnold SE, Lee VM, Gur RE, Trojanowski JQ: Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci USA 1991; 88:10850-10854
25. Rosoklija G, Mancevski B, Keilp J, Ilievsk B, Duma A, Filipovska A, Dwork AJ: Structural abnormalities of subicular dendrites in schizophrenia (abstract). Schizophr Res 2002; 53(suppl):108
26. Cotter D, Kerwin R, Doshi B, Martin CS, Everall IP: Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia. Brain Res 1997; 765:238-246
27. Cotter D, Wilson S, Roberts E, Kerwin R, Everall IP: Increased dendritic MAP2 expression in the hippocampus in schizophrenia. Schizophr Res 2000; 41:313-323
28. Allen PB, Ouimet CC, Greengard P: Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. Proc Natl Acad Sci USA 1997; 94:9956-9961
29. Alves SE, Hoskin E, Lee SJ, Brake WG, Ferguson D, Luine V, Allen PB, Greengard P, McEwen BS: Serotonin mediates CA1 spine density but is not crucial for ovarian steroid regulation of synaptic plasticity in the adult rat dorsal hippocampus. Synapse 2002; 45:143-151
30. Eastwood SL, Harrison PJ: Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol Psychiatry 2000; 5:425-432
31. Harrison PJ: The neuropathology of primary mood disorder. Brain 2002; 125:1428-1449
32. Kleinman JE, Hyde TM, Herman MM: Methodological issues in the neuropathology of mental illness, in Psychopharmacology: The Fourth Generation of Progress. Edited by Bloom FE, Kupfer DJ. New York, Raven Press, 1995, pp 859-864
33. Albala JS, Kalcheva N, Shafit-Zagardo B: Characterization of the transcripts encoding two isoforms of human microtubule-associated protein-2 (MAP-2). Gene 1993; 136:377-378
34. Webster MJ, Weickert CS, Herman MM, Kleinman JE: BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Brain Res Dev Brain Res 2002; 139:139-150
35. Law AJ, Deakin JF: Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. Neuroreport 2001; 12:2971-2974
36. Law AJ, Hutchinson LJ, Burnet PWJ, Harrison PJ: Antipsychotics increase microtubule-associated protein 2 mRNA but not spinophilin mRNA in the rat hippocampus and cortex. J Neurosci Res 2004; 76:376-382
37. Duvernoy HM: The Human Hippocampus: An Atlas of Applied Anatomy. Munich, Bergmann Verlag, 1988
38. Tucker RP, Garner CC, Matus A: In situ localization of microtubule-associated protein mRNA in the developing and adult rat brain. Neuron 1989; 2:1245-1256
39. Steward O, Wallace CS: mRNA distribution within dendrites: relationship to afferent innervation. J Neurobiol 1995; 26:447-449
40. Amateau SK, McCarthy MM: A novel mechanism of dendritic spine plasticity involving estradiol induction of prostaglandin-E2. J Neurosci 2002; 22:8586-8596
41. Represa A, Pollard H, Moreau J, Ghilini G, Khrestchatisky M, Ben Ari Y: Mossy fiber sprouting in epileptic rats is associated with a transient increased expression of alpha-tubulin. Neurosci Lett 1993; 156:149-152
42. Pollard H, Khrestchatisky M, Moreau J, Ben Ari Y, Represa A: Correlation between reactive sprouting and microtubule protein expression in epileptic hippocampus. Neuroscience 1994; 61:773-787
43. Montgomery MM, Dean AF, Taffs F, Stott EJ, Lantos PL, Luthert PJ: Progressive dendritic pathology in cynomolgus macaques infected with simian immunodeficiency virus. Neuropathol Appl Neurobiol 1999; 25:11-19
44. Hering H, Sheng M: Dendritic spines: structure, dynamics and regulation. Nat Rev Neurosci 2001; 2:880-888
45. Kasai H, Matsuzaki M, Noguchi J, Yasumatsu N, Nakahara H: Structure-stability-function relationships of dendritic spines. Trends Neurosci 2003; 26:360-368
46. Stephens DJ, Banting G: In vivo dynamics of the F-actin-binding protein neurabin-II. Biochem J 2000; 345(part 2):185-194
47. Feng J, Yan Z, Ferreira A, Tomizawa K, Liauw JA, Zhuo M, Allen PB, Ouimet CC, Greengard P: Spinophilin regulates the formation and function of dendritic spines. Proc Natl Acad Sci USA 2000; 97:9287-9292
48. Fiala JC, Spacek J, Harris KM: Dendritic spine pathology: cause or consequence of neurological disorders? Brain Res Brain Res Rev 2002; 39:29-54
49. Miwa C, Ueki A, Shinjo H, Simode H, Morita Y: Long-term synaptic alteration in the rat hippocampal CA3 field following an entorhinal cortex lesion. Psychiatry Clin Neurosci 2001; 55:573-578
50. Selkoe DJ: Alzheimer's disease is a synaptic failure. Science 2002; 298:789-791
51. Wong RO, Ghosh A: Activity-dependent regulation of dendritic growth and patterning. Nat Rev Neurosci 2002; 3:803-812
52. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT: Abnormal excitatory neu retransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995; 52:829-836
53. Tamminga C: Glutamatergic aspects of schizophrenia. Br J Psychiatry Suppl 1999; 37:12-15
54. Passafaro M, Nakagawa T, Sala C, Sheng M: Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR2. Nature 2003; 424:677-681
55. Eastwood SL, McDonald B, Burnet PW, Beckwith JP, Kerwin RW, Harrison PJ: Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Brain Res Mol Brain Res 1995; 29:211-223
56. Eastwood SL, Kerwin RW, Harrison PJ: Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biol Psychiatry 1997; 41:636-643
57. Robinson TE, Gorny G, Mitton E, Kolb B: Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 2001; 39:257-266
58. Norrholm SD, Ouimet CC: Altered dendritic spine density in animal models of depression and in response to antidepressant treatment. Synapse 2001; 42:151-163
59. Schwab C, Bondada V, Sparks DL, Cahan LD, Geddes JW: Postmortem changes in the levels and localization of microtubule-associated proteins (tau, MAP2 and MAP1B) in the rat and human hippocampus. Hippocampus 1994; 4:210-225
60. Eastwood SL, Heffernan J, Harrison PJ: Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes. Mol Psychiatry 1997; 2:322-329
61. Pei Q, Burnet PJ, Zetterstrom TS: Changes in mRNA abundance of microtubule-associated proteins in the rat brain following electroconvulsive shock. Neuroreport 1998; 9:391-394
62. Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, Barnes TR, Hirsch SR: Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 1998; 65:446-453
63. Glantz LA, Lewis DA: Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000; 57:65-73
64. Broadbelt K, Byne W, Jones LB: Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex. Schizophr Res 2002; 58:75-81